Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Meera Sridharan"'
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 6, Iss 5, Pp 458-464 (2022)
One of the treatment options for complement-mediated thrombotic microangiopathy (CM-TMA), also known as atypical hemolytic uremic syndrome, is the administration of the C5 complement inhibitor eculizumab. In vivo studies have reported a complete comp
Externí odkaz:
https://doaj.org/article/3597409f77ce433b921ef387bbd70d0e
Publikováno v:
HemaSphere, Vol 7, p e23733b0 (2023)
Externí odkaz:
https://doaj.org/article/f1233dec98ab429fa110db712372d378
Autor:
Julie Goswami, Taleen A. MacArthur, Meera Sridharan, Julie Tange, Andrew J. Kirmse, Kaitlin A. Lundell, Dong Chen, Matthew T. Auton, Tony Y. Chon, Ryan T. Hurt, Bradley R. Salonen, Ravindra Ganesh, Young M. Erben, Christopher P. Marquez, Jing-Fei Dong, Rosemary A. Kozar, Stephanie F. Heller, Erica A. Loomis, Andrea L. Johnstone, Kent R. Bailey, Grant M. Spears, Myung S. Park
Publikováno v:
Thrombosis Update, Vol 5, Iss , Pp 100090- (2021)
Background: COVID-19-associated coagulopathy is incompletely understood. Objectives: To characterize thrombin generation, Von Willebrand Factor (VWF), neutrophil extracellular traps (NETs), and their role in COVID-19 risk stratification in the emerge
Externí odkaz:
https://doaj.org/article/8e5b378ff9804fa482a694f139c9f846
Publikováno v:
Thrombosis Update, Vol 1, Iss , Pp 100002- (2020)
Atypical hemolytic uremic syndrome (aHUS) is a thrombotic microangiopathy (TMA) characterized by dysregulation of the alternative pathway of complement. Heterozygous variants in complement and complement regulatory proteins may increase risk for aHUS
Externí odkaz:
https://doaj.org/article/b5d52f1f6c9740369e58c456fcffb55f
Autor:
Adam J. Kanack, Jordan K. Schaefer, Meera Sridharan, Noah P. Splinter, Mindy C. Kohlhagen, Bandana Singh, Silvana B. De Lorenzo, Emily E. Mauch, Maen A. Hussein, Marwan Shaikh, Shaji Kumar, Renren Wen, Demin Wang, David Murray, Anand Padmanabhan
Publikováno v:
Blood. 141:1772-1776
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::499eac76235c5ea9512358c68e0397f3
https://doi.org/10.1182/blood.2022018797
https://doi.org/10.1182/blood.2022018797
Autor:
Damon E. Houghton, Waldemar E. Wysokinski, Leslie J. Padrnos, Surbhi Shah, Ewa Wysokinska, Rajiv Pruthi, Atefeh Ghorbanzadeh, Aneel Ashrani, Meera Sridharan, Robert D. McBane, Anand Padmanabhan, Ana I. Casanegra
Publikováno v:
American Journal of Hematology. 98:566-570
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a5f13d5dde08fe726b0e805e1f12edf
https://doi.org/10.1002/ajh.26848
https://doi.org/10.1002/ajh.26848
Autor:
Aldo A. Acosta-Medina, Ann M. Moyer, Ronald S. Go, Maria Alice V. Willrich, Fernando C. Fervenza, Nelson Leung, Christianne Bourlon, Jeffrey L. Winters, Grant M. Spears, Sandra C. Bryant, Meera Sridharan
Publikováno v:
Blood Advances. 7:340-350
Eculizumab is effective for complement-mediated thrombotic microangiopathy (CM-TMA), also known as atypical hemolytic uremic syndrome. Although lifelong therapy had been suggested, discontinuation does not universally lead to relapse. Comprehensive d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8964a6a229eefdca4bf349000553f02
https://doi.org/10.1182/bloodadvances.2021006416
https://doi.org/10.1182/bloodadvances.2021006416
Autor:
Shruti, Chaturvedi, Ana G, Antun, Andrew M, Farland, Ryan, Woods, Ara, Metjian, Yara A, Park, Gustaaf, de Ridder, Briana, Gibson, Raj S, Kasthuri, Darla K, Liles, Frank, Akwaa, Todd, Clover, Lisa, Baumann Kreuziger, J Evan, Sadler, Meera, Sridharan, Ronald S, Go, Keith R, McCrae, Harsh Vardhan, Upreti, Angela, Liu, Ming Y, Lim, Radhika, Gangaraju, X Long, Zheng, Jay S, Raval, Camila, Masias, Spero R, Cataland, Andrew, Johnson, Elizabeth, Davis, Michael D, Evans, Marshall A, Mazepa
Publikováno v:
Blood. 140:1335-1344
Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is characterized by recurring episodes of thrombotic microangiopathy, causing ischemic organ impairment. Black patients are overrepresented in iTTP cohorts in the United States, but racial di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bc4cc94bbaac641f87df27b51dd51a7
https://doi.org/10.1182/blood.2022016640
https://doi.org/10.1182/blood.2022016640
Autor:
John McGlothlin, Jithma P. Abeykoon, Eyad Al-Hattab, Aneel A. Ashrani, Michelle A Elliott, Ronald Go, C. Christopher Hook, Animesh Pardanani, Rajiv K. Pruthi, Meera Sridharan, Alexandra P. Wolanskyj
Publikováno v:
Blood. 140:5328-5330
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7fe79c7f750654176c0ffd75456a3c8a
https://doi.org/10.1182/blood-2022-159270
https://doi.org/10.1182/blood-2022-159270
Autor:
Karan Chohan, Saurabh Zanwar, Ronald Go, Jonas Paludo, Carrie A. Thompson, Asher Chanan-Khan, Sikander Ailawadhi, Thomas M. Habermann, Thomas E. Witzig, Morie A Gertz, Stephen M. Ansell, Shaji K Kumar, Rajiv K. Pruthi, William L. Nichols, Prashant Kapoor, Meera Sridharan, Jithma P. Abeykoon
Publikováno v:
Blood. 140:9363-9365
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7410c5c20c86b044a09e81fa7f66ed67
https://doi.org/10.1182/blood-2022-168232
https://doi.org/10.1182/blood-2022-168232